Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair

Journal of Vascular Research

Volumn 37, Issue 5, 2000, Pages 399-407

  Shi, Yi ^a   Niculescu, Rodica ^a   Wang, Dian ^a   Ormont, Michael ^a   Magno, Michael ^a   San Antonio, James D ^a   Williams, Kevin J ^a   Zalewski, Andrew ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Coronary artery; Glycosaminoglycans; Lipid; Myofibroblast; Versican

Indexed keywords

ALPHA ACTIN; CALDESMON; CHONDROITIN; CHONDROITIN ABC LYASE; DERMATAN SULFATE; GLUCOSAMINE; GLYCOSAMINOGLYCAN; LIPID; MYOSIN HEAVY CHAIN; PROTEOGLYCAN; VERSICAN;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; GLYCOSAMINOGLYCAN METABOLISM; HYPERLIPIDEMIA; LIPID STORAGE; MACROPHAGE MIGRATION; MYOFIBROBLAST; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SWINE; TISSUE REPAIR;

EID: 0033778803     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025756     Document Type: Article

References (48)

1. Wight TN: Cell biology of arterial proteoglycans. Arteriosclerosis 1989;9:1-20.
2. Camejo G, Hurt-Camejo E, Olsson U, Bondjers G: Proteoglycans and lipoproteins in atherosclerosis. Curr Opin Lipidol 1993;4:385-391.
3. Camejo G, Olofsson S-O, Lopez F, Carlsson P, Bondjers G: Identification of apoB-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis 1988;8:368-377.
4. Olsson U, Camejo G, Olofsson S-O, Bondjers G: Molecular parameters that control the association of low density lipoprotein apoB-100 with chondroitin sulphate. Biochim Biophys Acta 1991;1097:37-44.
5. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G: Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 1993;268:14131-14137.
6. Hollmann J, Schmidt A, von Bassewitz D-B, Budecke E: Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis 1989;9:154-158.
7. Cardoso LEM, Mourao PAS: Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 1994;1:115-124.
8. Galis ZS, Alavi MZ, Moore S: Co-localization of aortic apolipoprotein B and chondroilin sulfate in an injury model of atherosclerosis. Am J Pathol 1993;142:1432-1438.
9. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G, Bondjers G: Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 1992;12:569-583.
10. Stary HC, Chair A, Chandler B, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of the atherosclerosis. Circulation 1995;92:1355-1374.
11. Gown AM, Tsukada T, Ross R: Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125:191-207.
12. Dartsch PC, Bauriedel G, Schinko I, Weiss HD, Höfling B, Betz E: Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. Atherosclerosis 1989;80:149-157.
13. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN: Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 1998;152: 533-546.
14. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR: Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 1996;44:303-312.
15. Patel S, Shi Y, Niculescu R, Chung EH, Martin JL, Zalewski A: Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation 2000;101:524-532.
16. Christen T, Bochaton-Piallat ML, Neuville P, Rensen S, Redard M, van Eys G, Gabbiani G: Cultured porcine coronary artery smooth muscle cells: A new model with advanced differentiation. Circ Res 1999;85:99-107.
17. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A: Adventitial remodeling following coronary arterial injury. Circulation 1996; 93:340-348.
18. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN: Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93:2178-2187.
19. Shi Y, O'Brien JE, Fard A, Zalewski A: Transforming growth factor β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 1996;16:1298-1305.
20. Shi Y, O'Brien JE Jr, Fard A, Mannion JD, Wang D, Zalewski A: Advential myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996;94: 1655-1664.
21. Shi Y, O'Brien JE, Ala-Kokko L, Chung WS, Mannion JD, Zalewski A: Origin of extracellular matrix synthesis during coronary repair. Circulation 1997;95:997-1006.
22. Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G: Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 1997;29: 19-30.
23. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR: Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-2200.
24. Weiner BH, Ockene IS, Jarmolych J, Fritz KE, Jarmolych J, Fritz KE, Daoud AS: Comparison of pathologic and angiographic findings in a porcine preparation of coronary atherosclerosis. Circulation 1985;72:1081-1086.
25. Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883: 173-177.
26. Tao Z, Smart FW, Figueroa JE, Glancy DL, Vijagopal P: Elevated expression of proteoglycans in proliferating vascular smooth muscle cells. Atherosclerosis 1997;135:171-179.
27. Wight TN, Potter-Perigo S, Aulinskas T: Proteoglycans and vascular cell proliferation. Am Rev Respir Dis 1989;140:1132-1135.
28. Bassols A, Massagué J: Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988;263: 3039-3045.
29. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN: Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991;266:17640-17647.
30. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW: Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-658.
31. Nikkari ST, Jarvelainen HT, Wight TN, Ferguson M, Clowes AW: Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 1994;144:1348-1356.
32. Srinivasan SR, Xu J-H, Vijayagopal P, Radhakrishnamurthy B, Berenson GS: Injury to the arterial wall of rabbits produces proteoglycan variants with enhanced low-density lipoprotein-binding property. Biochim Biophys Acta 1993;1168:158-166.
33. Kuhn C, McDonald JA: The roles of the myofibroblast in idiopathic pulmonary fibrosis. Am J Pathol 1991;138:1257-1265.
34. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: α-Smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87: 847-858.
35. Faggin E, Puato M, Zardo L, Franch R, Millino C, Sarinella F, Pauletto P, Sartore S, Chiavegato A: Smooth muscle-specific SM22 protein is expressed in the adventitial cells of balloon-injured rabbit carotid artery. Arterioscler Thromb Vasc Biol 1999;19:1393-1404.
36. Shi Y, Patel S, Nieulescu R, Chung W, Dosrochers P, Zalewski A: Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol 1999;19:1150-1155.
37. Evanko SP, Angello JC, Wight TN: Formation of hyluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. ArteriosclerThromb Vasc Biol 1999;19:1004-1013.
38. Wight TN, Lara S, Riessen R, Le Baron R, Isner J: Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol 1997; 151:963-973.
39. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN: Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994;144:962-974.
40. Lin H, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM: Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allografts: Distinctness as compared with native atherosclerosis. J Heart Lung Transplant 1996;15:1233-1247.
41. O'Brien KD, Olin KL, Alpers CE, Chiu W, Fergusson M, Hudkins K, Wight TN, Chait A: Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques. Colocalization of higlycan with apolipoproteins. Circulation 1998;98:519-527.
42. Wight TN: The extracellular matrix and atherosclerosis. Curr Opin Lipidol 1995;6:326-334.
43. Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-561.
44. Hurt-Camejo E, Olson U, Wiklund O, Bondjers G, Camejo G: Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol 1997;17: 1011-1017.
45. Libby P, Ganz P, Restenosis revisited - New targets, new therapies. N Engl J Med 1997;337: 418-419.
46. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages. Proc Natl Acad Sci USA 1987;84:2995-2998.
47. Bjorkerud S, Bjorkerud B: Growth-stimulating effect of lipoproteins on human arterial smooth-muscle cells and lung fibroblasts is due to apo B-containing lipoproteins, type LDL and VLDL, and requires LDL receptors. Biochim Biophys Acta 1995;1268:237-247.
48. Jimi S, Saku K, Uesugi N, Sakata N, Takebayashi S: Oxidized low density lipoprotein stimulates collagen production on cultured arterial smooth muscle cells. Atherosclerosis 1995;116: 15-26.